Low Serum Calcium Concentration in Patients With Systemic Lupus Erythematosus Accompanied by the Enhanced Peripheral Cellular Immunity

Objective This study aims to explore the relationship between serum calcium concentration and peripheral lymphocyte status/Th1/Th2 cytokine levels in SLE patients, and the effect of glucocorticoids (GCs) on the calcium concentration and immune cell activation. Methods The peripheral blood TBNK lymphocyte subsets and Th1/Th2 cytokines in SLE patients with low or normal serum calcium concentration and healthy people were analyzed and compared retrospectively. Peripheral white blood cells (PWBCs) from SLE patients or healthy people were stimulated with PMA or GCs in vitro to test their extracellular calcium concentration and CD8+ T cell activation. Results The percentages of CD8+ T in SLE patients increased, but the increase of the number of CD8+ T cells only occurred in the SLE patients with low serum calcium concentration, and the number of CD45hiCD8+ T cells also increased, suggesting that SLE patients with hypocalcemia tend to possess an enhanced cellular immunity. The results of Th1/Th2 cytokines in peripheral blood showed that the levels of serum IL-2, IL-10, IL-6 and IFN-γ in SLE patients with hypocalcemia were significantly increased. Although the serum levels of TNF-α in SLE patients were –similar to that in healthy people, it was significantly higher than that in SLE patients with normal serum calcium. When comparing the results of Th1/Th2 cytokines in two times of one patient, the serum levels of TNF-α in SLE patients increased while serum calcium levels decreased. The in vitro experiments showed that the decrease of serum calcium concentration in SLE patients was affected by the immune cell activation and the application of GCs, but GCs did not promote the immune cell activation. Conclusions Low serum calcium may make SLE patients in an enhanced cellular immune status and GCs aggravates the decrease of serum calcium levels but has no role on the immune cell activation. It suggests that hypocalcemia possibly promotes the disease activity of SLE patient, which should be paid attention to clinically.

[1]  K. Zhao,et al.  Protein phosphatase 2A catalytic subunit β suppresses PMA/ionomycin‐induced T‐cell activation by negatively regulating PI3K/Akt signaling , 2022, The FEBS journal.

[2]  G. Alarcón,et al.  How well do the new classification criteria for SLE perform? , 2020, Nature Reviews Rheumatology.

[3]  K. Ikuta,et al.  Control of immunity by glucocorticoids in health and disease , 2020, Seminars in Immunopathology.

[4]  S. Feske,et al.  CRAC Channels and Calcium Signaling in T Cell-Mediated Immunity. , 2020, Trends in immunology.

[5]  F. de Vries,et al.  Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls , 2020, Rheumatology.

[6]  L. Trupin,et al.  Mortality Among Hospitalized Individuals With Systemic Lupus Erythematosus in the US Between 2006 and 2016 , 2020, Arthritis care & research.

[7]  V. Hornung,et al.  Molecular mechanisms and cellular functions of cGAS–STING signalling , 2020, Nature Reviews Molecular Cell Biology.

[8]  G. Nagy,et al.  Large-scale mortality gap between SLE and control population is associated with increased infection-related mortality in lupus , 2020, Rheumatology.

[9]  Lianping He,et al.  Total Serum Calcium Level Is Negatively Correlated With Systemic Lupus Erythematosus Activity , 2020, Dose-response : a publication of International Hormesis Society.

[10]  Zhengfan Jiang,et al.  Metalloimmunology: The metal ion-controlled immunity. , 2020, Advances in immunology.

[11]  G. Dellaire,et al.  An emerging role for calcium signalling in innate and autoimmunity via the cGAS-STING axis. , 2019, Cytokine & growth factor reviews.

[12]  F. Glowacki,et al.  Calcium state estimation by total calcium: the evidence to end the never-ending story , 2019, Clinical chemistry and laboratory medicine.

[13]  B. Treanor,et al.  Beyond the CRAC: Diversification of ion signaling in B cells , 2019, Immunological reviews.

[14]  D. Gladman,et al.  2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus , 2019, Arthritis & rheumatology.

[15]  S. Larsson,et al.  Genetic predisposition to increased serum calcium, bone mineral density, and fracture risk in individuals with normal calcium levels: mendelian randomisation study , 2019, BMJ.

[16]  K. Costenbader,et al.  Comparative Fracture Risks Among United States Medicaid Enrollees With and Those Without Systemic Lupus Erythematosus , 2019, Arthritis & rheumatology.

[17]  G. Hasan,et al.  IP3 receptors and Ca2+ entry. , 2019, Biochimica et biophysica acta. Molecular cell research.

[18]  R. Sun,et al.  The Ca2+ sensor STIM1 regulates type I interferon response by retaining the signaling adaptor STING at the endoplasmic reticulum , 2018, Nature Immunology.

[19]  M. Petri,et al.  Systemic lupus erythematosus: Diagnosis and clinical management. , 2019, Journal of autoimmunity.

[20]  B. Freedman,et al.  STIM- and Orai-mediated calcium entry controls NF-κB activity and function in lymphocytes. , 2018, Cell calcium.

[21]  S. Hillion,et al.  Could Lymphocyte Profiling be Useful to Diagnose Systemic Autoimmune Diseases? , 2017, Clinical Reviews in Allergy & Immunology.

[22]  H. Bading,et al.  Nuclear calcium is required for human T cell activation , 2016, The Journal of cell biology.

[23]  M. Prakriya,et al.  Structural and functional mechanisms of CRAC channel regulation. , 2015, Journal of molecular biology.

[24]  S. Feske,et al.  CD4⁺ and CD8⁺ T cell-dependent antiviral immunity requires STIM1 and STIM2. , 2014, The Journal of clinical investigation.

[25]  M. Hoth,et al.  Calcium, cancer and killing: the role of calcium in killing cancer cells by cytotoxic T lymphocytes and natural killer cells. , 2013, Biochimica et biophysica acta.

[26]  F. Lang,et al.  Regulation of ion channels by the serum‐ and glucocorticoid‐inducible kinase SGK1 , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  S. Feske,et al.  Ion channels , 2013, Thorax.

[28]  M. Takiguchi,et al.  Functional heterogeneity of human effector CD8+ T cells. , 2012, Blood.

[29]  P. Lipsky,et al.  Mechanisms of B cell autoimmunity in SLE , 2011, Arthritis research & therapy.

[30]  Sten Orrenius,et al.  Calcium and cell death mechanisms: a perspective from the cell death community. , 2011, Cell calcium.

[31]  J. Monroe,et al.  B‐cell targeted therapies in human autoimmune diseases: an updated perspective , 2010, Immunological reviews.

[32]  K. Chandy,et al.  Ion channels in lymphocytes , 2004, Journal of Clinical Immunology.